NCT01155388View on ClinicalTrials.gov

A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Nondialysis-Dependent Chronic Kidney Disease

PHASE3TerminatedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

October 17, 2011

Primary Completion Date

June 24, 2014

Study Completion Date

June 24, 2014

Conditions
Iron Deficiency AnemiaNondialysis-dependent Chronic Kidney Disease
Interventions
DRUG

Ferumoxytol

Experimental: Ferumoxytol

DRUG

Oral Iron

Active Comparator: Oral iron

Trial Locations (1)

02451

AMAG Pharmaceuticals, Inc., Waltham

Sponsors
All Listed Sponsors
lead

AMAG Pharmaceuticals, Inc.

INDUSTRY